> Search > Spinouts
Listing analysis and research matching Spinouts:
In a bid to cut costs AstraZeneca is spinning out its efforts to find new drugs for gastrointestinal (GI) disorders to a new company called Albireo. Part of the decision reflects AztraZeneca's recent problems with its drug, Nexium, an ulcer treatment, which has been declining in profit and its decision to direct its energies on respiratory, cancer and infectious diseases.
Silico Research is an independent research company that conducts research and provides data and advice on issues that impact innovation and research driven industries including the life sciences, health care, technology and energy. The areas covered by our research expertise include alliances, partnerships, technology, patents and intellectual property.
Click here to find out more.
Alliances Biotechnology Cancer China Collaboration Partnering Patents Pfizer Pharmaceuticals Research
1 Home page
2 BMS partnerships
3 Recent analysis
4 Biogenerics Asia
5 Balanced scorecards
| USA | 90% |
| European Union | 3% |
| Israel | 3% |
| Canada | 1% |
| Belgium | 1% |
| Netherlands | 1% |
| Norway | 1% |
| Slovenia | 1% |
| United Kingdom | 1% |
* Page views by country